Delveinsight's Extensive Coverage of

Eular 2022 Conference

Novel biomarkers in Rheumatic and Musculoskeletal Diseases

Novel biomarkers in Rheumatic and Musculoskeletal Diseases

Biomarker studies have added value to real-world data collections in inflammatory arthritis, and some of them have the potential to be used in routine clinical practice.

Read More
Digital/Remote Health Applications for Self-management in Patients With Rheumatic Diseases

Mobile health (mHealth) technologies can transform the mode and quality of healthcare by connecting patients, their families, and health care professionals by creating a network with mobile and specialized devices with wearable sensors, recording health parameters, and gathering health data.

Read More
Eli Lilly to present baricitinib’s results for juvenile idiopathic arthritis from its Phase III safety and efficacy study at EULAR 2022.

Eli Lilly will present its Phase III trial results of baricitinib for the treatment of Juvenile Idiopathic Arthritis (JIA), providing clarity on the emergence of a new JAK inhibitor in the JIA treatment space.

Read More
EULAR 2022: A glimpse of Abbvie’s Oral Presentation on Upadacitinib for treatment of Nonradiographic Axial Spondyloarthritis.

Abbvie has filed for approval of upadacitinib to the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for treatment of nr-axSpA based on Phase III SELECT-AXIS 2 (Study 2), whose results will be presented at EULAR 2022.

Read More
+ SHOW MORE
Loading
View All

Case Studies

Reports

adult onset stills disease
ankylosing spondylitis as market
axial spondyloarthritis market
behcet syndrome market
fibromyalgia epidemiology forecast
gout market
uvenile idiopathic arthritis
systemic sclerosis epidemiology
lupus nephritis market
osteoarthritis pipeline
polymyalgia rheumatica
psoriatic arthritis
rheumatoid arthritis
sjogrens syndrome
systemic lupus
juvenile rheumatoid arthritis

NEWSLETTER AND WHITEPAPERS

Gout Market

Gout Market is Anticipated to Expand Due to Active as well as Emerging Pipeline Therapies

Gout is a chronic disease caused by the deposition of monosodium urate (MSU) crystals in joints. It typically presents as an acute, self-limiting inflammatory monoarthritis that affects the joints of the lower limb. Various symptoms of Gout include intense joint pain, joint swelling, stiffness, tenderness, even to light touch, such as from a bedsheet, heat in the affected area, and joint redness.

Read More

Have any Project Plan?
Get Expert Consultation now!

Our long standing experience and rich expertise in the rheumatology domain can be a perfect partner for your pressing business problems

Our in-depth knowledge of the rheumatology pipeline, granular understanding of market dynamics and acute perception of marketing nuances can help you create a highly successful plan for future performance.
Get in touch with us to discuss potential partnership and to know more about what we can offer you.

Delivering value through our expansive service offerings

Taking into account the highly dynamic landscape of rheumatology therapy area, it is of utmost importance to attain competitive edge early on in your business. With our repository of consulting solutions and market research offerings, we are well-positioned to advise you on how to navigate the barriers as well as leverage your strengths and opportunities.

We impart insights aimed at leveraging competitive advantage and formulating effective business growth strategies. Journey with us to realize opportunities as well as pitfalls, as we make it easier for you to capitalize your return on investment through our expert advice.

Explore Rheumatology
Portfolio Management
Portfolio Management

Involve us to assist you in gathering insights on what asset might be the most promising in the future

Market Assessment
Market Assessment

Our 11-year forecast provides foresight for effective strategy-building for successful market entry

Competitive Intelligence
Competitive Intelligence

Our research expertise delivered real-time information that elevates your business decisions

R&D Analysis
Pipeline Assessment

We assist in navigating the tricky drug development terrain by providing intelligence assessments